Novo Nordisk A/S
NONOF
$49.68
$0.160.32%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.74% | 11.77% | 19.05% | 15.76% | 28.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.74% | 11.77% | 19.05% | 15.76% | 28.79% |
| Cost of Revenue | 28.12% | 36.04% | 31.81% | 25.94% | 24.80% |
| Gross Profit | -3.75% | 7.19% | 16.78% | 13.94% | 29.46% |
| SG&A Expenses | -7.77% | 0.98% | 23.49% | 8.30% | 7.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -137.12% | -- | 105.99% | -102.39% | 176.25% |
| Total Operating Expenses | 24.74% | 18.31% | 25.63% | 13.63% | 2.77% |
| Operating Income | -18.74% | 4.52% | 11.47% | 18.01% | 62.08% |
| Income Before Tax | 4.85% | -21.11% | 40.68% | 12.40% | 27.44% |
| Income Tax Expenses | 8.57% | -17.29% | 45.74% | 19.02% | 28.22% |
| Earnings from Continuing Operations | 3.89% | -22.10% | 39.35% | 10.71% | 27.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.89% | -22.10% | 39.35% | 10.71% | 27.24% |
| EBIT | -18.74% | 4.52% | 11.47% | 18.01% | 62.08% |
| EBITDA | -16.50% | 8.23% | 17.87% | 21.43% | 56.18% |
| EPS Basic | 3.95% | -21.95% | 39.80% | 11.21% | 27.77% |
| Normalized Basic EPS | -11.02% | 8.69% | 15.21% | 12.91% | 54.39% |
| EPS Diluted | 3.99% | -21.83% | 39.93% | 11.38% | 27.85% |
| Normalized Diluted EPS | -10.95% | 8.82% | 15.33% | 13.02% | 54.51% |
| Average Basic Shares Outstanding | -0.06% | -0.20% | -0.32% | -0.45% | -0.41% |
| Average Diluted Shares Outstanding | -0.14% | -0.31% | -0.42% | -0.54% | -0.49% |
| Dividend Per Share | 9.75% | -- | 12.95% | -- | 22.20% |
| Payout Ratio | -- | 0.46% | -- | 0.08% | -- |